BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24269922)

  • 1. Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin.
    Siddique A; Nelson JE; Aouizerat B; Yeh MM; Kowdley KV;
    Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1170-8. PubMed ID: 24269922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China.
    Pan X; Chen B; Liu W; Li Y; Hu Z; Lin X; Xu S; Peng XE
    Ann Nutr Metab; 2019; 74(3):207-214. PubMed ID: 30870854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE; Brunt EM; Kowdley KV;
    Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepcidin levels are associated with obesity but not liver disease.
    Vuppalanchi R; Troutt JS; Konrad RJ; Ghabril M; Saxena R; Bell LN; Kowdley KV; Chalasani N
    Obesity (Silver Spring); 2014 Mar; 22(3):836-41. PubMed ID: 23512600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 as a potential regulator of hepcidin homeostasis in overweight and obese children: a cross-sectional study in Taiwan.
    Chang JS; Li YL; Lu CH; Owaga E; Chen WY; Chiou HY
    Nutrition; 2014 Oct; 30(10):1165-70. PubMed ID: 25194615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
    BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin resistance in dysmetabolic iron overload.
    Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
    Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of fat loss after bariatric surgery on inflammation, serum hepcidin, and iron absorption: a prospective 6-mo iron stable isotope study.
    Cepeda-Lopez AC; Allende-Labastida J; Melse-Boonstra A; Osendarp SJ; Herter-Aeberli I; Moretti D; Rodriguez-Lastra R; Gonzalez-Salazar F; Villalpando S; Zimmermann MB
    Am J Clin Nutr; 2016 Oct; 104(4):1030-1038. PubMed ID: 27557657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Binetti J; Aguilar C; Porras JA; Molina A; Del Castillo D; Richart C
    PLoS One; 2017; 12(10):e0187065. PubMed ID: 29065180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity does not influence hepcidin and hemojuvelin levels in hemodialysis patients.
    Sarafidis PA; Rumjon A; Ackland D; MacLaughlin HL; Bansal SS; Brasse-Lagnel C; Macdougall IC
    Nephron Clin Pract; 2013; 124(3-4):159-66. PubMed ID: 24356769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hepcidin and 25-OH-Vitamin D Levels in Obese Children as a Potential Mediator of the Iron Status.
    Aka S; Kilercik M; Arapoglu M; Semiz S
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron homeostasis and serum hepcidin-25 levels in obese children and adolescents: relation to body mass index.
    Hamza RT; Hamed AI; Kharshoum RR
    Horm Res Paediatr; 2013; 80(1):11-7. PubMed ID: 23817203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased hepcidin levels and non-alcoholic fatty liver disease in obese prepubertal children: a further piece to the complex puzzle of metabolic derangements.
    Giannini C; Polidori N; Saltarelli MA; Chiarelli F; Basilico R; Mohn A
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):39-47. PubMed ID: 34726357
    [TBL] [Abstract][Full Text] [Related]  

  • 17.  Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.
    Handa P; Vemulakonda AL; Maliken BD; Morgan-Stevenson V; Nelson JE; Dhillon BK; Hennessey KA; Gupta R; Yeh MM; Kowdley KV
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):77-85. PubMed ID: 28051796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy.
    Garcia-Valdes L; Campoy C; Hayes H; Florido J; Rusanova I; Miranda MT; McArdle HJ
    Int J Obes (Lond); 2015 Apr; 39(4):571-8. PubMed ID: 25614087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.
    Shalitin S; Deutsch V; Tauman R
    J Endocrinol Invest; 2018 Aug; 41(8):969-975. PubMed ID: 29305826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
    Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
    Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.